Hannah E. Maier

848 total citations
18 papers, 493 citations indexed

About

Hannah E. Maier is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Hannah E. Maier has authored 18 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Hannah E. Maier's work include Respiratory viral infections research (9 papers), Influenza Virus Research Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Hannah E. Maier is often cited by papers focused on Respiratory viral infections research (9 papers), Influenza Virus Research Studies (7 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Hannah E. Maier collaborates with scholars based in United States, Nicaragua and Austria. Hannah E. Maier's co-authors include Aubree Gordon, Guillermina Kuan, Sergio Ojeda, Ángel Balmaseda, Roger López, Nery Sánchez, Lionel Gresh, Sophia Ng, Eva Harris and Raquel Burger‐Calderon and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Hannah E. Maier

17 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah E. Maier United States 10 227 219 119 61 54 18 493
David C. Gaston United States 12 186 0.8× 289 1.3× 88 0.7× 33 0.5× 38 0.7× 37 569
Lasata Shrestha United States 8 84 0.4× 602 2.7× 172 1.4× 54 0.9× 81 1.5× 13 726
Chunke Chen China 9 75 0.3× 415 1.9× 158 1.3× 32 0.5× 64 1.2× 16 525
Zhaomin Feng China 11 174 0.8× 187 0.9× 125 1.1× 16 0.3× 41 0.8× 38 429
Karen P. Acker United States 7 66 0.3× 214 1.0× 119 1.0× 32 0.5× 60 1.1× 19 526
Olha Puhach Switzerland 8 119 0.5× 464 2.1× 71 0.6× 40 0.7× 32 0.6× 9 592
Ikbel Hadj Hassine Tunisia 5 41 0.2× 213 1.0× 73 0.6× 28 0.5× 38 0.7× 7 312
Madeline R. Miller United States 6 399 1.8× 110 0.5× 196 1.6× 17 0.3× 52 1.0× 7 628
Priyanka Uprety United States 11 83 0.4× 186 0.8× 44 0.4× 24 0.4× 46 0.9× 19 345
Katherine McMahan United States 11 67 0.3× 502 2.3× 128 1.1× 67 1.1× 160 3.0× 16 646

Countries citing papers authored by Hannah E. Maier

Since Specialization
Citations

This map shows the geographic impact of Hannah E. Maier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah E. Maier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah E. Maier more than expected).

Fields of papers citing papers by Hannah E. Maier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah E. Maier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah E. Maier. The network helps show where Hannah E. Maier may publish in the future.

Co-authorship network of co-authors of Hannah E. Maier

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah E. Maier. A scholar is included among the top collaborators of Hannah E. Maier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah E. Maier. Hannah E. Maier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zambrana, José Víctor, Ian A. Mellis, Hannah E. Maier, et al.. (2025). Variant-specific antibody correlates of protection against SARS-CoV-2 Omicron symptomatic and overall infections. Nature Communications. 16(1). 10305–10305.
2.
Zambrana, José Víctor, et al.. (2024). Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines. Vaccines. 12(3). 326–326. 2 indexed citations
3.
Maier, Hannah E., Theresa Kowalski-Dobson, Ashley Eckard, et al.. (2024). Reduction in Long COVID Symptoms and Symptom Severity in Vaccinated Compared to Unvaccinated Adults. Open Forum Infectious Diseases. 11(2). ofae039–ofae039. 5 indexed citations
4.
Maier, Hannah E., Guillermina Kuan, Nery Sánchez, et al.. (2023). Increased influenza severity in children in the wake of SARS‐CoV‐2. Influenza and Other Respiratory Viruses. 17(7). e13178–e13178. 9 indexed citations
5.
Maier, Hannah E., Guillermina Kuan, Lionel Gresh, et al.. (2022). The Nicaraguan Pediatric Influenza Cohort Study, 2011–2019: Influenza Incidence, Seasonality, and Transmission. Clinical Infectious Diseases. 76(3). e1094–e1103. 5 indexed citations
6.
Hacker, Kathryn P., Guillermina Kuan, Gerardo Chowell, et al.. (2022). Pediatric burden and seasonality of human metapneumovirus over 5 years in Managua, Nicaragua. Influenza and Other Respiratory Viruses. 16(6). 1112–1121. 14 indexed citations
7.
Maier, Hannah E., Miguel Plazaola, Roger López, et al.. (2022). SARS‐CoV‐2 infection‐induced immunity and the duration of viral shedding: Results from a Nicaraguan household cohort study. Influenza and Other Respiratory Viruses. 17(1). e13074–e13074. 7 indexed citations
8.
Kubale, John, Ángel Balmaseda, Nery Sánchez, et al.. (2022). Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua. JAMA Network Open. 5(6). e2218794–e2218794. 7 indexed citations
9.
Kuan, Guillermina, Roger López, Nery Sánchez, et al.. (2022). The Spectrum of Influenza in Children. Clinical Infectious Diseases. 76(3). e1012–e1020. 26 indexed citations
10.
Maier, Hannah E., Guillermina Kuan, Saira Saborío, et al.. (2021). Clinical Spectrum of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Protection From Symptomatic Reinfection. Clinical Infectious Diseases. 75(1). e257–e266. 24 indexed citations
11.
Meade, Philip, Guillermina Kuan, Shirin Strohmeier, et al.. (2020). Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults. mBio. 11(1). 48 indexed citations
12.
Maier, Hannah E., Guillermina Kuan, Lionel Gresh, et al.. (2020). Obesity Is Associated With Increased Susceptibility to Influenza A (H1N1pdm) but Not H3N2 Infection. Clinical Infectious Diseases. 73(11). e4345–e4352. 11 indexed citations
13.
Maier, Hannah E., Raffael Nachbagauer, Guillermina Kuan, et al.. (2019). Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults. Clinical Infectious Diseases. 70(11). 2290–2297. 64 indexed citations
14.
Maier, Hannah E., Roger López, Nery Sánchez, et al.. (2018). Obesity Increases the Duration of Influenza A Virus Shedding in Adults. The Journal of Infectious Diseases. 218(9). 1378–1382. 158 indexed citations
15.
Oh, So‐Young, Hannah E. Maier, G. Richter, et al.. (2013). Vaccine Protection against Bacillus cereus-Mediated Respiratory Anthrax-Like Disease in Mice. Infection and Immunity. 81(3). 1008–1017. 8 indexed citations
16.
Garufi, Gabriella, Yating Wang, So‐Young Oh, et al.. (2012). Sortase-conjugation generates a capsule vaccine that protects guinea pigs against Bacillus anthracis. Vaccine. 30(23). 3435–3444. 23 indexed citations
17.
Beres, Stephen B., S. Wesley Long, Anthony R. Flores, et al.. (2011). Rapidly Progressive, Fatal, Inhalation Anthrax-like Infection in a Human: Case Report, Pathogen Genome Sequencing, Pathology, and Coordinated Response. Archives of Pathology & Laboratory Medicine. 135(11). 1447–1459. 45 indexed citations
18.
Steichen‐Gersdorf, Elisabeth, Martina Baumgartner, Alfons Kreczy, Hannah E. Maier, & F. M. Fink. (1997). Deletion mapping on chromosome 17p in medulloblastoma. British Journal of Cancer. 76(10). 1284–1287. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026